Compare MASI & CHWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MASI | CHWY |
|---|---|---|
| Founded | 1989 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 11.0B |
| IPO Year | 2000 | 2019 |
| Metric | MASI | CHWY |
|---|---|---|
| Price | $178.19 | $24.24 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 23 |
| Target Price | ★ $184.25 | $44.82 |
| AVG Volume (30 Days) | 2.0M | ★ 6.9M |
| Earning Date | 05-05-2026 | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 51.05 | ★ 911.11 |
| EPS | N/A | ★ 0.43 |
| Revenue | $1,239,153,000.00 | ★ $11,861,335,000.00 |
| Revenue This Year | $8.59 | $8.37 |
| Revenue Next Year | $7.60 | $8.99 |
| P/E Ratio | ★ N/A | $56.72 |
| Revenue Growth | ★ 8.34 | 6.40 |
| 52 Week Low | $125.94 | $23.06 |
| 52 Week High | $176.42 | $48.62 |
| Indicator | MASI | CHWY |
|---|---|---|
| Relative Strength Index (RSI) | 78.83 | 37.85 |
| Support Level | $157.54 | $23.06 |
| Resistance Level | N/A | $34.72 |
| Average True Range (ATR) | 0.37 | 1.01 |
| MACD | -1.13 | 0.00 |
| Stochastic Oscillator | 93.91 | 3.76 |
Masimo Corp is a medical technology company. The company oepates in single segment namely Healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The company sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, and others.
Chewy is the largest e-commerce petcare retailer in the US, generating $11.9 billion in fiscal 2024 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending time developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods like crates, leashes, and bowls.